Emily Fender Sizemore

This study evaluates CB2-specific antibody agonists for treating chemotherapy-induced peripheral neuropathy, showing pain relief without tolerance or off-target effects.

This study investigates the role of NAPE-PLD in opioid responsiveness and finds sex-dependent differences in oxycodone and sucrose consumption in knockout mice.

This study shows that genetic deletion of NAPE-PLD in mice leads to anxiety-like behaviors and context-dependent dysregulation of the HPA axis, with sex-specific effects on corticosterone levels.

This study shows that the CB1 receptor NAM GAT358 reduces opioid tolerance and withdrawal without impairing analgesia in mice.